Partner News | Published: Monday, March 6, 2023
MedAxiom, the cardiovascular community’s premier source for organizational performance solutions, is excited to announce a new partnership with Echo IQ. Echo IQ uses the latest artificial intelligence (AI) to help identify patients at risk of structural heart disease through their platform EchoSolv™.
“MedAxiom strives to connect healthcare providers with industry innovators to develop impactful solutions to everyday cardiovascular challenges. As part of this pursuit, we are pleased to partner with Echo IQ. While still a relative newcomer, Echo IQ has demonstrated the power and usefulness of using AI-powered technology to improve the diagnosis of structural heart disease and we look forward to seeing EchoSolv adopted on a larger scale,” said Joe Sasson, PhD, MedAxiom’s EVP of Ventures and chief commercial officer.
“We are honored to be a part of the MedAxiom community alongside such esteemed leaders in the field of cardiovascular healthcare. Our decision to partner with MedAxiom reflects our deep commitment to providing innovative solutions that meet the needs of cardiologists and their patients. We look forward to working together to advance cardiovascular care and improve patient outcomes,” said Don Fowler, Echo IQ’s President, USA.
Echo IQ’s cloud-based AI clinical decision-support tool analyzes echocardiographic measurement data from a standard cardiothoracic ultrasound to show probability and risk indicators for structural heart disease. The solution, which is designed to fit into existing workflows without additional steps, can be used to retrospectively review previous echos or in real-time to provide concurrent analysis.
“Echo IQ’s partnership with MedAxiom is exciting. It helps bring the new era in automated aortic stenosis detection to cardiovascular leaders and organizations across the U.S. Put simply, MedAxiom has enabled Echo IQ to help cardiologists improve patient care,” said David Playford, , FRACP (gen med), FRACP (cardiology), FCSANZ, FACC, FESC, MBBS, PhD, Echo IQ’s Chief Medical Advisor.
About MedAxiom
MedAxiom, an ACC Company, is the cardiovascular community’s premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of 475+ cardiovascular organization members, thousands of administrators, clinicians and revenue cycle experts, and 40+ industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience.
For additional information, visit MedAxiom.com.
About Echo IQ
Echo IQ offers a proprietary cloud-based solution, EchoSolv, backed by the latest in medical technology, AI and machine learning. The data is trained on and validated against the largest global database of echocardiograms tied to mortality and is HIPAA and SOCII compliant. Echo IQ is on a mission to help improve the lives of people by supporting earlier, more accurate detection of a number of life-threatening but often treatable cardiac conditions.
For additional information, visit EchoIQ.AI.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
